Acelyrin, Inc. (SLRN) Tops Q2 EPS by 22c

Acelyrin, Inc. (NASDAQ: SLRN) reported Q2 EPS of ($0.86), $0.22 better than the analyst estimate of ($1.08).

For earnings history and earnings-related data on Acelyrin, Inc. (SLRN) click here.

You May Also Be Interested In

• SanDisk stock target lifted by Citi on continued demand strength
• Canopy Growth (WEED:CN) (CGC) PT Lowered to Cdn$1.70 at Bernstein SocGen Group
• Glass Lewis backs MicroVision shareholder proposals ahead of July meeting